Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatitis × Pentoxifylline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Fibrosis 3 Colorectal Neoplasms 3 Mucositis 2 Head and Neck Neoplasms 2 Erectile Dysfunction 2 Sarcoidosis, Pulmonary 1 Prostatic Neoplasms 1 Primary Ovarian Insufficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Pentoxifylline, Cisplatin, Nephrotoxixcity 1 Pancreatitis, Alcoholic 1 Pancreatitis 1 Pain 1 Osteoradionecrosis 1 Non-small Cell Lung Cancers 1 Neuritis 1 Neoplasms 1 Lymphedema 1 Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1 Hodgkin Disease 1 HIV Infections 1 Gliosarcoma 1 Glioblastoma 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Capsular Contractures 1

Interventions

zegocractin 1 Postoperative Care 1 Pentoxifylline 1 Pantoprazole 1 Pancreatectomy 1 Octreotide 1 Hydrocortisone 1 Drainage 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02487225 2019-01-23

AP

Mayo Clinic

Phase 3 Completed

83 enrolled 11 charts

Pancreatitis, Pancreatitis, Alcoholic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡